Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03823144

Intravital Microscopy in Human Solid Tumors

Intravital Microscopy (IVM) in Human Solid Tumors

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
85 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the tumor-associated vasculature of patients with solid tumors. The investigators will use a technology known as intravital microscopy (IVM) in order to visualize in real-time the vessels associated with solid tumors. The IVM observations may determine if an individual patient's tumor vessels would be amenable to receiving systemic therapy, based on the functionality of the vessels.

Detailed description

PRIMARY OBJECTIVE: I. To determine the feasibility of performing human intravital microscopy (HIVM) in patients with deep space solid tumors during standard course of surgical resection. SECONDARY OBJECTIVES: I. Compare the microscopic observation of the tumor-associated vessels with normal tissue (e.g. peritoneal surface or normal brain tissue) in each individual subject. II. Correlate the microscopic observations of the tumor-associated vessels with pathologic grade of tumor. III. To correlate the microscopic observation of the microvasculature with tumor-specific and overall survival. OUTLINE: Patients receive fluorescein intravenously (IV) and undergo HIVM over 1-2 minutes per field. After completion of study, patients are followed up at 2-3 weeks after surgery.

Conditions

Interventions

TypeNameDescription
DEVICEDiagnostic MicroscopyUndergo Intravital microscopy (IVM), which allows real-time, direct visualization of microscopic blood vessels and calculation of blood flow.
DRUGFluorescein Sodium InjectionGiven IV as part of IVM procedure

Timeline

Start date
2019-02-28
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2019-01-30
Last updated
2025-12-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03823144. Inclusion in this directory is not an endorsement.